In response to "serum tumor marker use in patients with advanced solid tumors"

Farshid Dayyani; Dave Morgenstern; Stefan Holdenrieder

doi:10.1200/JOP.2015.009241

In response to "serum tumor marker use in patients with advanced solid tumors"

Farshid Dayyani
, Dave Morgenstern
, Stefan Holdenrieder

Roche Diagnostics International
University of Bonn

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	273-274
Number of pages	2
Journal	Journal of Oncology Practice
Volume	12
Issue number	3
DOIs	https://doi.org/10.1200/JOP.2015.009241
State	Published - Mar 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/JOP.2015.009241

Cite this

@article{377ba24e829f440c92834720e20e92f8,

title = "In response to {"}serum tumor marker use in patients with advanced solid tumors{"}",

author = "Farshid Dayyani and Dave Morgenstern and Stefan Holdenrieder",

year = "2016",

month = mar,

doi = "10.1200/JOP.2015.009241",

language = "English",

volume = "12",

pages = "273--274",

journal = "Journal of Oncology Practice",

issn = "1554-7477",

publisher = "American Society of Clinical Oncology",

number = "3",

}

TY - JOUR

T1 - In response to "serum tumor marker use in patients with advanced solid tumors"

AU - Dayyani, Farshid

AU - Morgenstern, Dave

AU - Holdenrieder, Stefan

PY - 2016/3

Y1 - 2016/3

UR - https://www.scopus.com/pages/publications/84962496767

U2 - 10.1200/JOP.2015.009241

DO - 10.1200/JOP.2015.009241

M3 - Letter

C2 - 26837562

AN - SCOPUS:84962496767

SN - 1554-7477

VL - 12

SP - 273

EP - 274

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

IS - 3

ER -

In response to "serum tumor marker use in patients with advanced solid tumors"

UN SDGs

Access to Document

Other files and links

Cite this